Skip to content
Recall Observatory FDA recall evidence

Drug product

Valsartan Tablets, USP 160 mg Rx Only 50 Tablets (5x10) Unit Dose NDC 50268-785-15 Manufactured for: AvKARE, Inc. Pulaski, TN 38478

D-1132-2018

August 14, 2018

Class II

Product summary

Firm
AVKARE Inc.
Event
Event 80828
Status
Terminated
Classification
Class II
Quantity
818 cartons (40,900 tablets)
Official record key
drug-enforcement:D-1132-2018

Official wording

Reason: CGMP Deviations: Carcinogen impurity detected in API used to manufacture drug product.

Code information: Lots: 17717 Exp. 07/2018; 18493 Exp. 01/2019; 19761 Exp. 04/2019

Distribution pattern: U.S. Nationwide

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations